Therapeutic effects of EGCG: a patent review

References

• World tea production and trade Current and future development. Food and agriculture organization of United Nation. 2015 [cited 2016 Mar 28]. Available from: http://www.fao.org
   Google Scholar
• Thakur VS, Gupta K, Gupta S. The chemopreventive and chemotherapeutic potentials of tea polyphenols. Curr Pharm Biotechnol. 2012;13:191–199.
   PubMed Web of Science ®Google Scholar
• Saito ST, Gosmann G, Pungartnik C, et al. Green tea extract-patents and diversity of uses. Recent Pat Food Nutr Agric. 2009;1:203–215.
   PubMedGoogle Scholar
• Reygaert WC. The antimicrobial possibilities of green tea. Front Microbiol. 2014;5:434.
   PubMed Web of Science ®Google Scholar
• Jeon J, Kim JH, Lee CK, et al. The antimicrobial activity of ()-epigallocatehin-3-gallate and green tea extracts against Pseudomonas aeruginosa and Escherichia coli isolated from skin wounds. Ann Dermatol. 2014;26:564–569.
   PubMed Web of Science ®Google Scholar
• Singh BN, Shankar S, Srivastava RK. Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochem Pharmacol. 2011;82:1807–1821.
   PubMed Web of Science ®Google Scholar
• Shen C, Chen L, Jiang L, et al. Neuroprotective effect of epigallocatechin-3-gallate in a mouse model of chronic glaucoma. Neurosci Lett. 2015;600:132–136.
   PubMed Web of Science ®Google Scholar
• Ahmed RS, Liu G, Renzetti A, et al. Biological and mechanistic characterization of novel prodrugs of green tea polyphenol epigallocatechin gallate analogs in human leiomyoma cell lines. J Cell Biochem. 2016. [Epub ahead of print], doi:10.1002/jcb.25533.
   Google Scholar
• De Jong WH, Borm PJ. Drug delivery and nanoparticles: applications and hazards. Int J Nanomedicine. 2008;3:133–149.
   PubMed Web of Science ®Google Scholar
• Sanna V, Pala N, Dessì G, et al. Single-step green synthesis and characterization of gold-conjugated polyphenol nanoparticles with antioxidant and biological activities. Int J Nanomedicine. 2014;9:4935–4951.
   PubMed Web of Science ®Google Scholar
• Tsai LC, Hsieh HY, Lu KY, et al. EGCG/gelatin-doxorubicin gold nanoparticles enhance therapeutic efficacy of doxorubicin for prostate cancer treatment. Nanomedicine. 2016;11:9–30.
   PubMed Web of Science ®Google Scholar
• Singh M, Bhatnagar P, Mishra S, et al. PLGA-encapsulated tea polyphenols enhance the chemotherapeutic efficacy of cisplatin against human cancer cells and mice bearing Ehrlich ascites carcinoma. Int J Nanomedicine. 2015;10:6789–6809.
   PubMed Web of Science ®Google Scholar
• Situ BC. Cancer Facts; [cited 2016 Mar 28]. Available from: http://www.cancer.org
   Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics. CA Cancer J Clin. 2015;65:5–29.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–674.
   PubMed Web of Science ®Google Scholar
• Chen SJ, Yao XD, Peng B, et al. Epigallocatechin-3-gallate inhibits migration and invasion of human renal carcinoma cells by downregulating matrix metalloproteinase-2 and matrix metalloproteinase-9. Exp Ther Med. 2016;11:1243–1248.
   PubMed Web of Science ®Google Scholar
• Zhu K, Wang W. Green tea polyphenol EGCG suppresses osteosarcoma cell growth through upregulating miR-1. Tumour Biol. 2016;37:4373–4382.
   PubMed Web of Science ®Google Scholar
• Koh YW, Choi EC, Kang SU, et al. Green tea (−)-epigallocatechin-3-gallate inhibits HGF-induced progression in oral cavity cancer through suppression of HGF/c-Met. J Nutr Biochem. 2011;22:1074–1083.
   PubMed Web of Science ®Google Scholar
• Bettuzzi S, Brausi M, Rizzi F, et al. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Cancer Res 2006;66:1234–1240.
   Google Scholar
• Kumar NB, Pow-Sang J, Egan KM, et al. Randomized, placebo-controlled trial of green tea catechins for prostate cancer prevention. Cancer Prev Res. 2015;8:879–887.
   PubMed Web of Science ®Google Scholar
• Nicolai S, Rossi A, Di Daniele N, et al. DNA repair and aging: the impact of the p53 family. Aging. 2015;7:1050–1065.
   PubMedGoogle Scholar
• Kürbitz C, Heise D, Redmer T, et al. Epicatechin gallate and catechin gallate are superior to epigallocatechin gallate in growth suppression and anti‐inflammatory activities in pancreatic tumor cells. Cancer Sci. 2011;102:728–734.
   PubMed Web of Science ®Google Scholar
• Mayr C, Wagner A, Neureiter D, et al. The green tea catechin epigallocatechin gallate induces cell cycle arrest and shows potential synergism with cisplatin in biliary tract cancer cells. BMC Complement Altern Med. 2015;15:194.
   PubMed Web of Science ®Google Scholar
• Du GJ, Zhang Z, Wen XD, et al. Epigallocatechin Gallate (EGCG) is the most effective cancer chemopreventive polyphenol in green tea. Nutrients. 2012;4:1679–1691.
   PubMed Web of Science ®Google Scholar
• EGCG: Potent extract of green tea. Intelligent Medicine. 2013 [cited 2016 Mar 28]. Available from: http://www.drhoffman.com
   Google Scholar
• Xie H, Sun J, Chen Y, et al. EGCG attenuates uric acid-induced inflammatory and oxidative stress responses by medicating the NOTCH pathway. Oxid Med Cell Longev. 2015;2015:214836.
   PubMed Web of Science ®Google Scholar
• Srividhya R, Jyothilakshmi V, Arulmathi K, et al. Attenuation of senescence-induced oxidative exacerbations in aged rat brain by (−)-epigallocatechin-3-gallate. Int J Dev Neurosci. 2008;26:217–223.
   PubMed Web of Science ®Google Scholar
• Gao Z, Han Y, Hu Y, et al. Targeting HO-1 by epigallocatechin-3-gallate reduces contrast-induced renal injury via anti-oxidative stress and anti-inflammation pathways. Plos One. 2016;11:e0149032.
   PubMed Web of Science ®Google Scholar
• Hu B, Ting Y, Zeng X, et al. Bioactive peptides/chitosan nanoparticles enhance cellular antioxidant activity of (−)-epigallocatechin-3-gallate. J Agric Food Chem. 2013;61:875–881.
   PubMed Web of Science ®Google Scholar
• Chen L, Zhang HY. Cancer preventive mechanisms of the green tea polyphenol (-)-epigallocatechin-3-gallate. Molecules. 2007;12:946–957.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Tang J, Du Y, et al. The green tea polyphenol EGCG potentiates the antiproliferative activity of sunitinib in human cancer cells. Tumour Biol. 2016 Jan 5. doi:10.1007/s13277-015-4719-x. [Epub ahead of print].
   Google Scholar
• Katiyar SK, Afaq F, Azizuddin K, et al. Inhibition of UVB-induced oxidative stress-mediated phosphorylation of mitogen-activated protein kinase signaling pathways in cultured human epidermal keratinocytes by green tea polyphenol (−)-epigallocatechin-3-gallate. Toxicol Appl Pharmacol. 2001;176:110–117.
   PubMed Web of Science ®Google Scholar
• Maeda-Yamamoto M, Suzuki N, Sawai Y, et al. Association of suppression of extracellular signal-regulated kinase phosphorylation by epigallocatechin gallate with the reduction of matrix metalloproteinase activities in human fibrosarcoma HT1080 cells. J Agric Food Chem. 2003;51:1858–1863.
   PubMed Web of Science ®Google Scholar
• Fraley DS, Adler S, Bruns F, et al. Metabolic acidosis after hyperalimentation with casein hydrolysate: occurrence in a starved patient. Ann Intern Med. 1978;88:352–354.
   PubMed Web of Science ®Google Scholar
• Li M, Li JJ, Gu QH, et al. EGCG induces lung cancer A549 cell apoptosis by regulating Ku70 acetylation. Oncol Rep. 2016;35:2339–2347.
   PubMed Web of Science ®Google Scholar
• Ma J, Shi M, Li G, et al. Regulation of Id1 expression by epigallocatechin-3-gallate and its effect on the proliferation and apoptosis of poorly differentiated AGS gastric cancer cells. Int J Oncol. 2013;43:1052–1058.
   PubMed Web of Science ®Google Scholar
• Liu S, Xu ZL, Sun L, et al. ()-Epigallocatechin-3-gallate induces apoptosis in human pancreatic cancer cells via PTEN. Mol Med Rep. 2016; doi:10.3892/mmr.2016.5277. [Epub ahead of print].
   Google Scholar
• Siddiqui IA, Bharali DJ, Nihal M, et al. Excellent anti-proliferative and pro-apoptotic effects of (−)-epigallocatechin-3-gallate encapsulated in chitosan nanoparticles on human melanoma cell growth both in vitro and in vivo. Nanomedicine. 2014;10:1619–1626.
   PubMed Web of Science ®Google Scholar
• University of South Florida. Tea polyphenol esters and analogs thereof for cancer prevention and treatment. US6713506; 2004.
   Google Scholar
• SRI International. Analogs of green tea polyphenols as chemotherapeutic and chemopreventive agents. US7109236; 2006.
   Google Scholar
• SRI International. Analogs of green tea polyphenols as chemotherapeutic and chemopreventive agents. US7122573; 2006.
   Google Scholar
• Purdue Research Foundation. Compositions and methods based on synergies between capsicum extracts and tea catechins for prevention and treatment of cancer. US7192612; 2007.
   Google Scholar
• Lifeline Nutraceuticals Corporation. Preparation of compositions to alleviate inflammation and oxidative stress in a mammal. US7384655; 2008.
   Google Scholar
• Lifeline Nutraceuticals Corporation. Methods for enhancing antioxidant enzyme activity and reducing c-reactive protein levels. US7579026; 2009.
   Google Scholar
• Research Development Foundation. Polyphenol inhibition of nucleoside diphosphate kinase-B activity and cancer metastasis. US7678549; 2010.
   Google Scholar
• Genprofilers.r.l. Mixture of catechins or rather polyphenols extracted from Chinese green tea or other vegetables for the prevention of prostate cancer and for the treatment of prostate hypertrophy (BPH). US8044095; 2011.
   Google Scholar
• MediGene AG Use of a polyphenol for the treatment of a cancerous or precancerous lesion of the skin. US8455022; 2013.
   Google Scholar
• University of South Florida, McGill University and The Hong Kong Polytechnic University. Polyphenol proteasome inhibitors, synthesis, and methods of use. US8563607; 2013.
   Google Scholar
• Agency for Science, Technology and Research. Particulate hyaluronic acid/flavonoid suspensions for cellular delivery of bioactive agents. US8753687; 2014.
   Google Scholar
• Gold Nanotech, Inc. Physical nano-complexes for preventing and treating cancer and method for manufacturing the same. US8759546; 2014.
   Google Scholar
• Mayo Foundation for Medical Education and Research. Methods of treating hematologic cancers. US8772264; 2014.
   Google Scholar
• Georgia Regents Research Institute. Oral care compositions for treating xerostomia. US8920854; 2014.
   Google Scholar
• The Hong Kong Polytechnic University, Wayne State University, University of south florida and McGILL University. (–)-Epigallocatechin gallate derivatives for inhibiting proteasome. US9169230; 2015.
   Google Scholar
• WM. Wrigley Jr. Company. Oral compositions for skin benefits. US9186348; 2015.
   Google Scholar
• Agency for Science, Technology and Research. Particulate hyaluronic acid and flavonoid formulations for cellular delivery of bioactive agents. US9226899; 2016.
   Google Scholar
• Agency for Science, Technology and Research. Method of delivering an anti-cancer agent to a cell. US9248200; 2016.
   Google Scholar
• Kassi E, Pervanidou P, Kaltsas G, et al. Metabolic syndrome: definitions and controversies. BMC Med. 2011;9:48.
   PubMed Web of Science ®Google Scholar
• Keske MA, Ng HL, Premilovac D, et al. Vascular and metabolic actions of the green tea polyphenol epigallocatechin gallate. Curr Med Chem. 2015;22:59–69.
   PubMed Web of Science ®Google Scholar
• Chen IJ, Liu CY, Chiu JP, et al. Therapeutic effect of high-dose green tea extract on weight reduction: a randomized, double-blind, placebo-controlled clinical trial. Clin Nutr. 2015;22:59–69.
   Google Scholar
• Hill AM, Coates AM, Buckley JD, et al. Can EGCG reduce abdominal fat in obese subjects? J Am Coll Nutr. 2007;26:396S–402S.
   PubMed Web of Science ®Google Scholar
• Kucera O, Mezera V, Moravcova A, et al. In vitro toxicity of epigallocatechin gallate in rat liver mitochondria and hepatocytes. Oxid Med Cell Longev. 2015;2015:476180.
   PubMed Web of Science ®Google Scholar
• Collins QF, Liu HY, Pi J, et al. Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, suppresses hepatic gluconeogenesis through 5′-AMP-activated protein kinase. J Biol Chem. 2007;282:30143–30149.
   PubMed Web of Science ®Google Scholar
• Zhang J, Nie S, Wang S. Nanoencapsulation enhances epigallocatechin-3-gallate stability and its antiatherogenic bioactivities in macrophages. J Agric Food Chem. 2013;61:9200–9209.
   PubMed Web of Science ®Google Scholar
• Zhang J, Nie S, Martinez-Zaguilan R, et al. Formulation, characteristics and antiatherogenic bioactivities of CD36-targeted epigallocatechin gallate (EGCG)-loaded nanoparticles. J Nutr Biochem. 2016;30:14–23.
   PubMed Web of Science ®Google Scholar
• Moorthi C, Kathiresan K. Nanotoxicology: toxicity of engineered nanoparticles and approaches to produce safer nanotherapeutics. Int J Pharm Sci. 2012;2:117–124.
   Google Scholar
• Laboratoires Arkopharma. Green tea extract for treating obesity. US6830765; 2004.
   Google Scholar
• Herbalife International, Inc. Herbal supplement to support weight loss. US7329419; 2008.
   Google Scholar
• DSM IP Assets B.V. Compositions comprising epigallocatechingallate and protein hydrolysate. US8129337; 2012.
   Google Scholar
• FHG Corporation. Dietary supplements containing extracts of aronia and methods of using same to promote weight loss. US8158683; 2012.
   Google Scholar
• Finley;Jahahreeh. Compositions and methods for the prevention and treatment of diseases or conditions associated with oxidative stress, inflammation, and metabolic dysregulation. US8652518; 2014.
   Google Scholar
• Nuc Electronics Co.Ltd. Composition for controlling increase in blood glucose. US9180156; 2015.
   Google Scholar
• Nusirt Sciences,Inc. Compositions and methods for modulating metabolic pathways. US9198883; 2015.
   Google Scholar
• Purdue Research Foundation. Compositions and methods for treating and preventing virus infections. US7491413; 2009.
   Google Scholar
• Immune Guard, LLC. Methods and materials for reducing risk of cold and/or flu. US8465782; 2013.
   Google Scholar
• Cook Medical Technologies. Compositions and devices incorporating water-insoluble therapeutic agents and methods of the use thereof. US9180226; 2015.
   Google Scholar
• University of South Florida and Natura Therapeutics, Inc. Methods and compositions for improving bioavailability of epigallocatechingallate (EGCG). US8906414; 2014.
   Google Scholar
• New York University. Method for enhancing remyelination using GLI1 inhibitors. US9248128; 2016.
   Google Scholar
• Antibiotic Resistance Threats in the United States. U.S. Department Health Hum Serv. 2013 [cited 2016 Mar 28]. Available from: http://www.cdc.gov.org
   Google Scholar
• Taylor PW, Hamilton-Miller JM, Stapleton PD. Antimicrobial properties of green tea catechins. Food Sci Technol Bull. 2005;2:71–81.
   PubMedGoogle Scholar
• Yun B, Oh S, Song M, et al. Inhibitory effect of epigallocatechin gallate on the virulence of clostridium difficile PCR ribotype 027. J Food Sci. 2015;80:M2925–31.
   Google Scholar
• Brown RC, Lockwood AH, Sonawane BR. Neurodegenerative diseases: an overview of environmental risk factors. Environ Health Perspect. 2005;113:1250–1256.
   PubMed Web of Science ®Google Scholar
• Murpy MP, LeVine III H. Alzheimer’s disease and the β-amyloid peptide. J Alzheimers Dis. 2010;19:311–323.
   PubMed Web of Science ®Google Scholar
• O’Brien RJ, Wong PC. Amyloid precursor protein processing and Alzheimer’s disease. Annu Rev Neurosci. 2011;34:185–204.
   PubMed Web of Science ®Google Scholar
• Walker JM, Klakotskaia D, Ajit D, et al. Beneficial effects of dietary EGCG and voluntary exercise on behavior in an Alzheimer’s disease mouse model. J Alzheimers Dis. 2015;44:561–572.
   PubMed Web of Science ®Google Scholar
• Rasoolijazi H, Joghataie MT, Roghani M, et al. The beneficial effect of (-)-epigallocatechin-3-gallate in an experimental model of Alzheimer’s disease in rat: a behavioral analysis. Iranian Biomed J. 2007;11:237–243.
   PubMedGoogle Scholar
• Wang LY, Li X, Han YZ. Neuroprotection by epigallo catechin gallate against bupivacaine anesthesia induced toxicity involves modulation of PI3/Akt/PTEN signalling in N2a and SH-SY5Y cells. Int J Clin Exp Med. 2015;8:15065–15075.
   PubMed Web of Science ®Google Scholar